Evidence map›Paper›PMID 32358539›Full record

ArticleNature communications2020

The kallikrein-kinin pathway as a mechanism for auto-control of brown adipose tissue activity.

Marion Peyrou, Rubén Cereijo, Tania Quesada-López, Laura Campderrós, Aleix Gavaldà-Navarro, Laura Liñares-Pose, Elena Kaschina, Thomas Unger, Miguel López, Marta Giralt and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Marion PeyrouDepartament de Bioquímica i Biomedicina Molecular, Institut de Biomedicina, Universitat de Barcelona (IBUB) and CIBER Fisiopatología de la Obesidad y Nutrición, Avda Diagonal 643, 08028, Barcelona, Spain.ORCID http://orcid.org/0000-0002-1210-6094
Rubén CereijoDepartament de Bioquímica i Biomedicina Molecular, Institut de Biomedicina, Universitat de Barcelona (IBUB) and CIBER Fisiopatología de la Obesidad y Nutrición, Avda Diagonal 643, 08028, Barcelona, Spain.
Tania Quesada-LópezDepartament de Bioquímica i Biomedicina Molecular, Institut de Biomedicina, Universitat de Barcelona (IBUB) and CIBER Fisiopatología de la Obesidad y Nutrición, Avda Diagonal 643, 08028, Barcelona, Spain.ORCID http://orcid.org/0000-0002-7818-4351
Laura CampderrósDepartament de Bioquímica i Biomedicina Molecular, Institut de Biomedicina, Universitat de Barcelona (IBUB) and CIBER Fisiopatología de la Obesidad y Nutrición, Avda Diagonal 643, 08028, Barcelona, Spain.
Aleix Gavaldà-NavarroDepartament de Bioquímica i Biomedicina Molecular, Institut de Biomedicina, Universitat de Barcelona (IBUB) and CIBER Fisiopatología de la Obesidad y Nutrición, Avda Diagonal 643, 08028, Barcelona, Spain.ORCID http://orcid.org/0000-0001-8421-3174
Laura Liñares-PoseGrupo NeurObesity, Departamento de Fisiología, CiMUS, Universidade de Santiago de Compostela-Instituto de Investigación Sanitaria and CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), 15706, Santiago de Compostela, Spain.ORCID http://orcid.org/0000-0003-4567-6998
Elena KaschinaCharité Universitäts medizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universitätzu Berlin, and Berlin Institute of Health, Institute of Pharmacology, Center for Cardiovascular Research (CCR), Berlin, Germany.
Thomas UngerCARIM-School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.
Miguel LópezGrupo NeurObesity, Departamento de Fisiología, CiMUS, Universidade de Santiago de Compostela-Instituto de Investigación Sanitaria and CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), 15706, Santiago de Compostela, Spain.ORCID http://orcid.org/0000-0002-7823-1648
Marta GiraltDepartament de Bioquímica i Biomedicina Molecular, Institut de Biomedicina, Universitat de Barcelona (IBUB) and CIBER Fisiopatología de la Obesidad y Nutrición, Avda Diagonal 643, 08028, Barcelona, Spain.ORCID http://orcid.org/0000-0001-7968-4190
Francesc VillarroyaDepartament de Bioquímica i Biomedicina Molecular, Institut de Biomedicina, Universitat de Barcelona (IBUB) and CIBER Fisiopatología de la Obesidad y Nutrición, Avda Diagonal 643, 08028, Barcelona, Spain. fvgombau@gmail.com.ORCID http://orcid.org/0000-0003-1266-9142
Centro de Investigación Biomédica en Red · ESUniversidade de Santiago de Compostela · ESHumboldt-Universität zu Berlin · DEMaastricht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brown adipose tissue (BAT) is known to secrete regulatory factors in response to thermogenic stimuli. Components of the BAT secretome may exert local effects that contribute to BAT recruitment and activation. Here, we found that a thermogenic stimulus leads to enhanced secretion of kininogen (Kng) by BAT, owing to induction of kininogen 2 (Kng2) gene expression. Noradrenergic, cAMP-mediated signals induce KNG2 expression and release in brown adipocytes. Conversely, the expression of kinin receptors, that are activated by the Kng products bradykinin and [Des-Arg9]-bradykinin, are repressed by thermogenic activation of BAT in vivo and of brown adipocytes in vitro. Loss-of-function models for Kng (the circulating-Kng-deficient BN/Ka rat) and bradykinin (pharmacological inhibition of kinin receptors, kinin receptor-null mice) signaling were coincident in showing abnormal overactivation of BAT. Studies in vitro indicated that Kng and bradykinin exert repressive effects on brown adipocyte thermogenic activity by interfering the PKA/p38 MAPK pathway of control of Ucp1 gene transcription, whereas impaired kinin receptor expression enhances it. Our findings identify the kallikrein-kinin system as a relevant component of BAT thermogenic regulation that provides auto-regulatory inhibitory signaling to BAT.

Indexed as

Adipose Tissue, BrownAnimalsBradykininEndocrine SystemFluorescent Antibody TechniqueKallikreinsKininogensKininsMaleMiceMice, Inbred C57BLMice, KnockoutReal-Time Polymerase Chain ReactionSignal TransductionBradykininKallikreinsKininogensKinins

Identifiers

PMID32358539
PMCPMC7195474
OpenAlexW3022911118

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.